UNICHEM LABORATORIES
Back to Balance Sheet
|
UNICHEM LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹3,707 Cr | ₹3,544 Cr | ₹3,268 Cr | ₹3,183 Cr | ₹3,314 Cr |
What is the latest Total Liabilities ratio of UNICHEM LABORATORIES ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹3,707 Cr |
| Mar2025 | ₹3,544 Cr |
| Mar2024 | ₹3,268 Cr |
| Mar2023 | ₹3,183 Cr |
| Mar2022 | ₹3,314 Cr |
How is Total Liabilities of UNICHEM LABORATORIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,707 Cr | 4.61 | |
| Mar2025 | ₹3,544 Cr | 8.43 | |
| Mar2024 | ₹3,268 Cr | 2.68 | |
| Mar2023 | ₹3,183 Cr | -3.97 | |
| Mar2022 | ₹3,314 Cr | - | |
Compare Total Liabilities of peers of UNICHEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| UNICHEM LABORATORIES | ₹4,502.1 Cr | 37.8% | 45.5% | 11.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
UNICHEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| UNICHEM LABORATORIES | 37.8% |
45.5% |
11.4% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses